全ゲノム解析は,アロマターゼ阻害に対する乳がんの反応を告げる
Matthew J Ellis1, Li Ding, Dong Shen
1Department of Internal Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA.
Nature
|June 23, 2012
まとめ
エストロゲン受容体陽性乳がんの体内変異は,明確な臨床特徴と相関しています. MAP3K1やTP53のような特定の遺伝子変異は,腫瘍のサブタイプと治療への反応を予測し,将来の精密医療アプローチを導く.
科学分野:
- 腫瘍学 腫瘍学
- ゲノミクスゲノミクスとは
- 分子生物学は分子生物学である.
背景:
- エストロゲン受容体陽性 (ER+) 乳がんは,臨床的特徴が変動する.
- これらの変異の遺伝的基盤を理解することは,標的型療法にとって極めて重要です.
研究 の 目的:
- ER+乳がんの臨床的特徴と体内遺伝子の変異を相関させる.
- 腫瘍サブタイプと関連した特定の変異を特定し,ネオアジュバントアロマターゼ阻害剤療法への応答を特定する.
主な方法:
- ネオアジュバントアロマターゼ阻害剤療法を受けている患者の治療前の腫瘍バイオプシの分析.
- 重要な遺伝子の体内の変異を特定するために,大規模な並列配列を解析する.
主要な成果:
- RUNX1,CBFB,MYH9,MLL3,SF3B1を含む18の著しく変異した遺伝子が特定され,その中には以前から血液学的疾患と関連していたものもあります.
- 変異したMAP3K1は,光のA状態,低グレード,低増殖と関連していたが,変異したTP53は逆のパターンを示した.
- 変異したGATA3は,アロマターゼ阻害剤の治療中に抑制された増殖と相関し,MAP2K4の変異はMAP3K1の損失効果を模倣した.
結論:
- 明確なER+乳がんのフェノタイプは,細胞経路に影響を与える特定の体的変異パターンと関連しています.
- 再発性突然変異は稀ですが,腫瘍生物学と潜在的な治療標的の洞察を提供します.
- 将来の臨床試験では,パーソナライズされた治療戦略のためのこれらの発見を活用するために,包括的なゲノム配列決定を必要とします.
関連する概念動画
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...